Mitchall G Clark - EVP & Chief R & QA Officer, Atara Biotherapeutics, Inc

As of May 21, 2018


Mitchall G Clark Net Worth

  • Net worth is estimated to be at least $9.56M
  • Owns at least 107,972 units of Atara Biotherapeutics, Inc stock
  • Sold an estimated value of $8.05M in the last 4 years at Atara Biotherapeutics, Inc

Mitchall G Clark Trading

  • Largest purchase of shares was 72,754 units , worth over $1.59M on March 28, 2018
  • Largest sale of shares was 100,203 units , worth over $3.8M on March 28, 2018
  • In total has made about 24 transactions over 4 years
  • Usually trades in February, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mitchall G Clark Mailing Address

  • Mailing address is C/o Atara Biotherapeutics, Inc. 3260 Bayshore Boulevard Brisbane CA 94005 CA

Atara Biotherapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Pascal Touchon, D.V.M. 2020 $654,857 $422,500 $2,235,600 $1,959,208 $13,662 $5,285,827
Pascal Touchon, D.V.M. 2019 $319,327 $334,791 $2,861,712 $3,049,718 $71,760 $6,637,307
Jakob Dupont, M.D. 2020 $319,231 $143,346 $443,075 $1,757,296 $133,297 $2,796,245
Utpal Koppikar 2020 $460,947 $187,032 $885,431 $597,073 $7,470 $2,137,953
Utpal Koppikar 2019 $439,875 $155,606 $1,034,714 $909,080 $895 $2,540,170
Utpal Koppikar 2018 $240,289 $189,771 $1,903,500 $1,886,325 $398 $4,220,282
Joseph Newell 2020 $466,055 $203,435 $1,033,965 $566,713 $895 $2,251,063
Joseph Newell 2019 $390,000 $155,208 $1,240,675 $932,390 $895 $2,719,167
Joseph Newell 2018 $365,000 $155,490 $895,000 $1,060,710 $16,092 $2,492,292
Kristin Yarema, Ph.D. 2020 $368,308 $147,995 $668,250 $1,067,484 $184,370 $2,436,407
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm

Atara Biotherapeutics, Inc Insider Trading

  • The most recent transaction was 10,500 units sold on September 24, 2021 by Joe Newell worth over $178.5K
  • In the last 7 years, insiders at Atara Biotherapeutics, Inc sold an estimated value of $71.44M and bought an estimated value of $10.23M
  • The most active traders are Isaac E Ciechanover, Chief Executive Officer,  Christopher Haqq, EVP,  and Joe Newell, Chief Operations Officer
  • Insider trading is most common in February, with the busiest year in 2018

Atara Biotherapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1